PRP works better than SynVisc, better in Patients with Mild Arthritis

By /

PRP works better than SynVisc

In this corner, the world’s most commonly used biologic injectable for knee arthritis-SynVisc. In the other corner, your own platelets, a.k.a. PRP. The winner? Well a study published last week may help decide that honor. Platelet Rich Plasma (PRP) is now being used in patients with knee arthritis. However, there isn’t that much research yet published that shows it works in these patients. I blogged several months ago about a few studies showing that PRP tends to work better in patients with more mild and early arthritis than in patients with more severe arthritis and that stem cells tended to work better for patients with more severe arthritis. A more recent study adds more fuel to this fire, this time comparing Hyaluronic acid (HA) (SynVisc, OrthoVisc, Hyalgan, Supartz, etc…) to PRP for knee arthritis patients. The study involved 150 patients affected by both early and severe knee arthritis. Fifty symptomatic patients were treated with 3 PRP injections into the joint and two other groups of patients were treated with HA injections. One group was treated with injections of high-molecular weight HA (thicker HA like SynVisc); the other group was treated with low-molecular weight HA (thinner HA like Hyalgan). At 2 months’ follow-up, the PRP and thinner HA groups showed a similar improvement, with better results compared with the high-molecular weight HA group (thicker HA). At 6 months’ follow-up, better results were observed in the PRP group. PRP and HA treatments offered similar results in patients 50 or older. The conclusion states that better results were seen in younger and more active patients who had a low degree of cartilage degeneration, whereas a worse outcome was seen in more advanced knee arthritis joints and in older patients. The upshot? PRP seems to work better than HA and neither works well in patients with more severe arthritis. This fits with what we see in our Colorado clinic, with many of our successful knee stem cell patients already having failed PRP and HA. This also fits with other recent studies showing that PRP is better than steroid shots for problems like plantar fascititis.

This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.

Get health and wellness information from a trusted source.

By submitting the form, you are agreeing that you read and consent to our Privacy Policy. We may also contact you via email, phone, and other electronic means to communicate information about our products and services. We do not sell, or share your information to third party vendors.

Category: Knee, Latest News

Is Regenexx Right For You?

Request a free Regenexx Info Packet

REGENEXX WEBINARS

Learn about the #1 Stem Cell & Platelet Procedures for treating arthritis, common joint injuries & spine pain.

Join a Webinar

RECEIVE BLOG ARTICLES BY EMAIL

Get fresh updates and insights from Regenexx delivered straight to your inbox.

Subscribe to the Blog

CONTACT US

9035 Wadsworth Pkwy #1000
Westminster, CO 80021
888-525-3005

FOLLOW US

Copyright © Regenexx 2020. All rights reserved. | Privacy Policy

*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.

Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.

LinkedIn
Email
TO TOP